Related Experiment Video
Updated: Jun 5, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
[Chronic respiratory diseases and atherosclerosis]
Shinji Teramoto1, Shunsuke Akashi
1Department of Pulmonary Medicine, National Health Organization, Tokyo National Hospital.
Abstract:
Chronic respiratory diseases including chronic obstructive pulmonary disease (COPD) are recently recognized as systemic inflammatory disorders and considered to be a new risk factor for atherosclerosis. The increased serum levels of C-reactive protein, TNF, VEGF, IL-6, and ICAM-1 were known in patients with COPD. The accelerated pulse wave velocity(PWV) and the increased intima-media thickness of internal jugular artery were significantly found in the patients, when compared with the smokers without COPD. The anti-atherogenic agents including statins and ARBs are reported to be effective for the reduced mortality in the patients. The possibility of COPD as a novel atherogenic factor is discussed.
More Related Videos
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
07:35Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease I: Introduction
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease II: Emphysema